MRNA250516C17500
- 10.95
- 0.000.00%
Moderna Newsroom
Unusual Options Activity: WFC, BBD and Others Attract Market Bets, WFC V/OI Ratio Reaches 206.9
'Trump To Sign Order To Cut Some U.S. Drug Prices To Match Those Abroad' - CNBC
Notable Healthcare Headlines for the Week: Viatris, Novavax and UnitedHealth in Focus
Trump Says 'GREAT PROGRESS MADE' at U.S.-China Trade Talks, Which Will Resume Sunday
Top Gap Ups and Downs on Thursday: AZN, MELI, APP and More
FDA to Speed up AI Rollout to Accelerate Drug Reviews
FDA Advisory Panel to Discuss Makeup of Updated COVID Shots
Unusual Options Activity: FN, SHOP and Others Attract Market Bets, FN V/OI Ratio Reaches 120.8
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
Moderna Options Spot-On: On May 7th, 174.2K Contracts Were Traded, With 823.14K Open Interest
Moderna Study Shows Immune Response in Older Adults for a Combo Flu and COVID-19 Shot
Daily short sale tracking: Palantir's short volume increased by 10 million, with a short sale ratio of 12%
Benchling and Moderna Collaborate on AI-Driven Research
Forget the Fed. Why Stocks Are Focused on -2-
Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.
① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.
Top Gap Ups and Downs on Tuesday: PLTR, VRTX, CEG and More
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers
Moderna Options Spot-On: On May 6th, 81,823 Contracts Were Traded, With 789.79K Open Interest
Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator
These Stocks Are Moving the Most Today: Palantir, Tesla, Ford, Constellation Energy, SolarEdge, Moderna, Hims & Hers, DoorDash, and More -- Barrons.com